BioXcel Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Greg Harrison. You may begin.
Hi and welcome to the Bank of America SMID Biotech Virtual Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And today, I'm happy to introduce BioXcel Therapeutics, represented by Vimal Mehta, CEO; Matt Wiley, Chief Commercial Officer; and Rob Risinger, Chief Medical Officer.
Thanks for joining us, everybody. And for those of you out there watching, if you want to send you questions, I'm happy to ask on your behalf. Vimal, would you like to start off with some opening remarks, and then we can jump into Q&A.
Thanks, Greg. Good afternoon, everyone. I'm Vimal Mehta,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |